Search

everythinglearnresearchcommunity

for

Search:↓

The hydrogel helps reduce scarring and improve wound healing by releasing salvianolic acid B in acidic conditions.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Helium-neon laser treatment can stimulate hair growth in mice.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Strict regulations may slow down new LLLT treatments.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Excimer light therapy is more effective than low level laser therapy for treating alopecia areata.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

A new laser treatment may help regrow hair in men with pattern baldness and has minimal side effects.

Clascoterone safely promotes hair growth similar to minoxidil.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

The treatment improved facial structure and corrected bite issues in patients.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

A new method accurately measures a drug in skin for cancer therapy research.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

Transplanted bone marrow cells actively move, form clusters, and grow after transplantation.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.